GlycoMimetics (NASDAQ:GLYC) Earns Overweight Rating from Analysts at Cantor Fitzgerald
Cantor Fitzgerald started coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a research note published on ...
Technology Networks6d
RNA-Editing Protein May Improve Cancer and Autoimmune Disease Treatment
Researchers uncover new insights into the molecular mechanisms of ADAR1, a protein that regulates RNA-induced immune ...
New insights into ADAR1 mechanisms could revolutionize autoimmune and cancer therapies
A research team led by Rice University's Yang Gao has uncovered new insights into the molecular mechanisms of ADAR1, a protein that regulates ribonucleic acid (RNA) induced immune responses.
Mirage News6d
RNA-Editing Protein Breakthrough May Boost Cancer Treatment
A research team led by Rice University's Yang Gao has uncovered new insights into the molecular mechanisms of ADAR1, a protein that regulates ...
Interesting Engineering on MSN6d
Scientists unravel RNA-editing mystery, paving way for next-gen cancer treatments
Scientists have made a major discovery about ADAR1—a protein that controls RNA-induced immune responses—paving ...
Allakos Inc. (NASDAQ:ALLK) Short Interest Down 18.8% in February
Allakos Inc. (NASDAQ:ALLK – Get Free Report) was the recipient of a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 1,940,000 ...
EurekAlert!6d
Scientists gain insight into RNA-editing protein that could lead to improved treatment for cancer, autoimmune diseases (IMAGE)
Welch Foundation, Cancer Prevention and Research Institute of Texas, NIH/National Institutes of Health ...